Eagle Rock Investment Company, LLC Laboratory Corp Of America Holdings Transaction History

Eagle Rock Investment Company, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$209.01 - $232.56 $264,606 - $294,420	-1,266 Reduced 13.54%	8,086 $1.77 Million
Q4 2023 Jan 12, 2024	SELL	$197.69 - $227.29 $71,959 - $82,733	-364 Reduced 3.75%	9,352 $2.13 Million
Q3 2023 Oct 10, 2023	SELL	$201.05 - $221.7 $62,727 - $69,170	-312 Reduced 3.11%	9,716 $1.95 Million
Q2 2023 Jul 19, 2023	SELL	$211.93 - $241.33 $44,717 - $50,920	-211 Reduced 2.06%	10,028 $2.42 Million
Q1 2023 Apr 10, 2023	SELL	$213.32 - $257.83 $686,890 - $830,212	-3,220 Reduced 23.92%	10,239 $2.35 Million
Q4 2022 Jan 25, 2023	SELL	$203.72 - $248.97 $123,046 - $150,377	-604 Reduced 4.29%	13,459 $0
Q3 2022 Nov 08, 2022	SELL	$204.81 - $262.19 $80,695 - $103,302	-394 Reduced 2.73%	14,063 $2.88 Million
Q2 2022 Aug 12, 2022	SELL	$213.86 - $277.87 $2.37 Million - $3.08 Million	-11,102 Reduced 43.44%	14,457 $3.39 Million
Q1 2022 May 11, 2022	BUY	$259.82 - $298.18 $794,529 - $911,834	3,058 Added 13.59%	25,559 $6.74 Million
Q4 2021 Feb 17, 2022	BUY	$271.6 - $314.21 $6.11 Million - $7.07 Million	22,501 New	22,501 $7.07 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Eagle Rock Investment Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Rock Investment Company, LLC with notifications on news.